back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-07 12:17 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,336,300 | |
| Filed 2025-07-04 12:43 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2025-07-04 12:43 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,336,300 | |
| Filed 2024-05-01 23:54 Tx date 2024-04-29 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,200
+555,000 vol $0.04 each |
1,236,300 | |
| Filed 2023-06-01 18:29 Tx date 2023-05-15 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+565,000 vol |
681,300 | |
| Filed 2023-01-12 13:51 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-170,800
-140,000 vol $1.22 each |
116,300 | |
| Filed 2023-01-12 13:50 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-152,600
-140,000 vol $1.09 each |
256,300 | |
| Filed 2023-01-12 13:49 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-77,000
-140,000 vol $0.55 each |
396,300 | |
| Filed 2023-01-12 13:48 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-191,070
-173,700 vol $1.10 each |
536,300 | |
| Filed 2021-12-13 14:01 Tx date 2021-12-08 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,850
+245,000 vol $0.13 each |
710,000 | |
| Filed 2021-05-08 13:00 Tx date 2021-05-07 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$170,800
+140,000 vol $1.22 each |
465,000 | |
| Filed 2020-09-18 19:43 Tx date 2020-09-16 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,600
+140,000 vol $1.09 each |
325,000 | |
| Filed 2019-12-06 10:46 Tx date 2019-12-02 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,000
+140,000 vol $0.55 each |
185,000 | |
| Filed 2019-06-21 13:55 Tx date 2019-06-13 |
$APLI
Appili Therapeutics Inc. |
Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
45,000 |